<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">Clinical and epidemiologic information have been used by most countries to determine who should be tested [
 <xref ref-type="bibr" rid="CR22">22</xref>]. In the USA, diagnostic testing indications were limited at the beginning of the outbreak secondary to regulatory procedures for the new tests. Subsequently, the FDA released policies to allow laboratories to use their validated assays. On March 4, 2020, the Centers for Disease Control and Prevention (CDC) removed restrictive testing criteria, encouraging the clinicians to use their judgment to determine whether a test should be performed. At present, the CDC recommends two criteria for testing [
 <xref ref-type="bibr" rid="CR23">23</xref>]. The high priority category includes hospitalized patients with symptoms, healthcare facility workers, and residents in long-term care facilities or other congregate living settings with symptoms. The priority category includes persons with symptoms of suspected COVID-19 infection and persons without symptoms who are prioritized by healthcare providers, for any reason, including public health monitoring or screening according to state and local plans. The CDC does not recommend testing for asymptomatic persons.
</p>
